Valuation Concerns Rise… And A Technical Take...

Financials surging as investors countdown to second quarter bank earnings next week, expecting major growth. The traders break down what the results could mean for these names and whether banks will see major gains. Then, shares of Kymera Therapeutics soaring as its Eczema drug t ...  Show more

CNBC's Melissa Lee speaks with David Li, Hesai's co-founder and CEO, about the company's partnership with Nvidia, concerns over potential cybersecurity risks, and how Hesai is responding as scrutiny of Chinese technology firms continues to grow. Hosted by Simplecast, an AdsWizz c ...  Show more

Technology stocks have gotten clobbered this year, and investor attention has focused on rising interest rates as the reason behind it. But that’s not the whole story, says Bloomberg Intelligence Chief Equity Strategist Gina Martin Adams.On this episode, she helps dissect the shi ...  Show more

Volatility has come roaring in after a long summer break and technology stocks are taking a hit after five months of historic gains. What is the options market telling us about the future direction for U.S. markets? Plus, a few good minutes with Ali Velshi, a global business corr ...  Show more

Scott Wapner and the Investment Committee discuss the stormy stock market and how to navigate all the uncertainty. Plus, Josh Brown gives an update on why he’s getting rid of one stock in his “Best Stocks in the market List” And later, Tanaya Macheel joins us with the latest n ...

Lots of sensational headlines this week on the risks to stocks with technology names being labeled the 'Big Tech Hype'.

So should investors be worried or are the tech stocks just trading at a fair valuation?

Join us for an episode that promises not only to ...